← Leaderboards
Brigid Reynolds
Georgetown University
$8,313,229
Attributed
$17,815,641
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,815,641 · 3
By mechanism
R01$17,761,253 · 2
M01$54,388 · 1
Top collaborators
- Jacobo E. Mintzer4 shared
- Paul S. Aisen1 shared
- Olga Brawman-Mintzer1 shared
- Michael S Rafii1 shared
Most similar at Georgetown University
Same institution · by research overlap
- Ludise Malkova$8,461,599
- Cherie L Marvel$4,802,804
- Hongfang Liu$19,184,300
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposDouble-Blind MethodS DiseasePlacebosRandomizedPharmaceutical PreparationsOralQuality Of LifeClinical TrialsAgitationNeuropsychiatryOpen LabelHospice CarePlacebo Controlled StudyCannabidiolDementiaDoseCannabinoidsCaregiver BurdenCaregiversClinical Research SiteCaringNational Institute On AgingEquipment And Supply Inventories
Grant awards (5)
Lifeâs end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study$2,072,617
R01 · FY2025 · AG
LifeâÃÂÃÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial$4,560,787
R01 · FY2022 · AG
LifeâÃÂÃÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial$5,332,036
R01 · FY2021 · AG
Life's end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial$5,795,813
R01 · FY2020 · AG
PF-04494700 IN PARTICIPANTS WITH MILD-TO-MODERATE ALZHEIMERS'S DISEASE$54,388
M01 · FY2009 · RR · contact PI